– FDA lifts PTC518 partial clinical hold based on PIVOT-HD data – – Conference call and webcast to be held June 20th at 8:00 am EDT – WARREN, N.J., June 20, 2024 /PRNewswire/ — PTC Therapeutics, Inc. (NASDAQ: PTCT) today shared interim results from the Phase 2 PIVOT-HD study of PTC518 in…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.